Search General Info
Search Education
Search Partnering Companies

Lovick Cannon, PhD

Tucker, Georgia, United States
Dr. Cannon has held staff and faculty positions at Harvard Medical School, Brandeis University, and the University of Massachusetts Medical School. He was a founder and Chief Scientific Officer for Hygeia Sciences, developer of the First Response™ Home Pregnancy and Ovulation Predictor products, the first monoclonal antibody-based home diagnostic products. He was CEO of Protein Engineering Technology, developer of phage display technology, and led the merger with Biotage to form Dyax Corp, where he was President of Dyax’s Therapeutic and Diagnostics business unit and led Dyax’s Kalbitor™ recombinant protein HAE therapeutic development program. Subsequent to Dyax he has participated in a number of early stage biotechnology companies including Adipogenix (CEO), a small molecule discovery company focused on adipocyte biology acquired by OSI Pharmaceuticals and Smart Cells Inc. (Director), developer of a novel glucose responsive insulin composition acquired by Merck.
Speaking In
[On Demand]

We have developed a new class of mAbs and a novel multimeric ligand technology for cell/tissue…